Investigation of Pathogenic and Truncated Variants of RUNX1 and DDX41 in All of Us
Cancer Genomics Consortium via YouTube
Start speaking a new language. It’s just 3 weeks away.
Master Windows Internals - Kernel Programming, Debugging & Architecture
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore a comprehensive investigation into pathogenic and truncated variants of RUNX1 and DDX41 genes within the All of Us research program. Presented by Huan Mo at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting, this 11-minute conference talk delves into the significance of these genetic variations in cancer genomics. Learn about the latest findings and their potential impact on accurate cancer diagnosis and personalized treatment strategies. Gain insights into the collaborative efforts of clinical cytogeneticists, molecular geneticists, and molecular pathologists in advancing cancer genomics research and clinical practice.
Syllabus
Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us
Taught by
Cancer Genomics Consortium